STEAP mRNA detection in serum of patients with solid tumours

Cancer Letters

Volumn 273, Issue 1, 2009, Pages 122-126

  Valenti, M T ^a   Dalle Carbonare, L ^a   Donatelli, L ^a   Bertoldo, F ^a   Giovanazzi, B ^a   Caliari, F ^a   Lo Cascio, V ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Cancer; RNA; RT Real Time PCR; Serum

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXIDOREDUCTASES; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 56349115303     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.037     Document Type: Article

References (13)

1. Hubert R.S., Vivanco I., Chen E., Rastegar S., Leong K., Mitchell S.C., et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumours. Proc. Natl. Acad. Sci. USA 96 (1999) 14523-14528
2. Alves P.M., Faure O., Graff-Dubois S., Cornet S., Bolonakis I., Gross D.A., et al. STEAP, a prostate tumour antigen, is a target of human CD8+ T cells. Cancer Immunol. Immunother. 55 (2006) 1515-1523
3. Prevarskaya N., Skryma R., Bidaux G., Flourakis M., and Shuba Y. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ. 14 (2007) 1295-1304
4. Smith P., Rhodes N.P., Shortland A.P., Fraser S.P., Djamgoz M.B., Ke Y., et al. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett. 423 (1998) 19-24
5. Laniado M.E., Lalani E.N., Fraser S.P., Grimes J.A., Bhangal G., Djamgoz M.B., et al. Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am. J. Pathol. 150 (1997) 1213-1221
6. Skryma R.N., Prevarskaya N.B., Dufy-Barbe L., Odessa M.F., Audin J., and Dufy B. Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation. Prostate 33 (1997) 112-122
7. Zhou H., Xu W., Qian H., Yin Q., Zhu W., and Yan Y. Circulating RNA as a novel tumour marker: an in vitro study of the origins and characteristics of extracellular RNA. Cancer Lett. 259 (2008) 50-60
8. Fleischhacker M. Biology of circulating mRNA still more questions than answers. Ann. N.Y. Acad. Sci. 1075 (2006) 40-49
9. Miura N., Shiota G., Nakagawa T., Maeda Y., Sano A., Marumoto A., et al. Sensitive detection of hTERT mRNA in the serum of patients with hepatocellular carcinoma. Oncology 64 (2003) 430-434
10. Dolly J.O., and Parcej D.N. Molecular properties of voltage-gated K+ channels. J. Bioenerg. Biomembr. 28 (1996) 231-253
11. Jørgensen N.R., Teilmann S.C., Henriksen Z., Civitelli R., Sørensen O.H., and Steinberg T.H. Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. J. Biol. Chem. 278 (2003) 4082-4086
12. Challita-Eid P.M., Morrison K., Etessami S., An Z., Morrison K.J., Perez-Villar J.J., et al. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumour xenografts in vivo. Cancer Res. 67 (2007) 5798-5805
13. Sanchez-Pulido L., Rojas A.M., Valencia A., Martinez A.C., and Andrade M.A. ACRATA: a novel electron transfer domain associated to apoptosis and cancer. BMC Cancer 29 (2004) 98-103